Secondary Malignancies after CAR-T Cell Therapy

被引：0
|
作者：
Rudek, Loreen Sophie [1 ]
Alakus, Hakan [1 ]
机构：
[1] Univ klinikum Koln AoR, Klin & Poliklin Allgemein Viszeral Tumor & Transpl, Kerpener Str 62, D-50937 Cologne, Germany
来源：
ONKOLOGIE | 2025年 / 31卷 / 01期
关键词：
D O I：
10.1007/s00761-024-01612-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] Secondary malignancies after CAR-T cell therapy
    Lorenz, Judith
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (22) : 1312 - 1313
  • [2] Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
    Bruce L. Levine
    Marcelo C. Pasquini
    John E. Connolly
    David L. Porter
    Michael P. Gustafson
    Jaap J. Boelens
    Edwin M. Horwitz
    Stephan A. Grupp
    Marcela V. Maus
    Frederick L. Locke
    Fabio Ciceri
    Annalisa Ruggeri
    John Snowden
    Helen E. Heslop
    Crystal L. Mackall
    Carl H. June
    Anna M. Sureda
    Miguel-Angel Perales
    Nature Medicine, 2024, 30 : 338 - 341
  • [3] Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
    Levine, Bruce L.
    Pasquini, Marcelo C.
    Connolly, John E.
    Porter, David L.
    Gustafson, Michael P.
    Boelens, Jaap J.
    Horwitz, Edwin M.
    Grupp, Stephan A.
    Maus, Marcela V.
    Locke, Frederick L.
    Ciceri, Fabio
    Ruggeri, Annalisa
    Snowden, John
    Heslop, Helen E.
    Mackall, Crystal L.
    June, Carl H.
    Sureda, Anna M.
    Perales, Miguel-Angel
    NATURE MEDICINE, 2024, 30 (02) : 338 - 341
  • [4] Resistance and recurrence of malignancies after CAR-T cell therapy
    Zeng, Wanying
    Zhang, Pumin
    EXPERIMENTAL CELL RESEARCH, 2022, 410 (02)
  • [5] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [6] T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies
    Maurer, Katie
    Jacobson, Caron A.
    LEUKEMIA & LYMPHOMA, 2025,
  • [7] Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
    Tao, Zhongfei
    Chyra, Zuzana
    Kotulova, Jana
    Celichowski, Piotr
    Mihalyova, Jana
    Charvatova, Sandra
    Hajek, Roman
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [8] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [9] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [10] Current Progress in CAR-T Cell Therapy for Hematological Malignancies
    Han, Donglei
    Xu, Zenghui
    Zhuang, Yuan
    Ye, Zhenlong
    Qian, Qijun
    JOURNAL OF CANCER, 2021, 12 (02): : 326 - 334
12345